Hostname: page-component-848d4c4894-75dct Total loading time: 0 Render date: 2024-06-01T03:23:31.323Z Has data issue: false hasContentIssue false
  • English
  • Français

C3-epimer of 25-hydroxyvitamin D3 in maternal-cord dyads

Published online by Cambridge University Press:  28 August 2013

J. Y. Zhang ,
M. Kinsella ,
A. J. Lucey ,
K. D. Cashman  and
M. Kiely
J. Y. Zhang
Affiliation:
Vitamin D Research Group, School of Food and Nutritional Sciences, University College Cork, Ireland
M. Kinsella
Affiliation:
Vitamin D Research Group, School of Food and Nutritional Sciences, University College Cork, Ireland
A. J. Lucey
Affiliation:
Vitamin D Research Group, School of Food and Nutritional Sciences, University College Cork, Ireland
K. D. Cashman
Affiliation:
Vitamin D Research Group, School of Food and Nutritional Sciences, University College Cork, Ireland
M. Kiely
Affiliation:
Vitamin D Research Group, School of Food and Nutritional Sciences, University College Cork, Ireland
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Abstract
Information
Proceedings of the Nutrition Society , Volume 72 , Issue OCE3: Irish Section Meeting, 19–21 June 2013, Childhood nutrition and obesity: current status and future challenges , 2013 , E138
Copyright
Copyright © The Authors 2013 

Circulating total serum 25-hydroxyvitamin D (25OHD) is the most appropriate biomarker for the assessment of vitamin D status. Total 25OHD is the sum of 25OHD2 and 25OHD3 in serum. While the C3 epimer of 25OHD3 (3-epi-25OHD3) has been detected in serum from adults and infants( Reference Strathmann, Sadilkova and Laha 1 , Reference Stepman, Vanderroost, Stöckl and Thienpont2 ), very little is known about the bioactivity of the 3-epi series of vitamin D structural analogs. As a result, 3-epi-25OHD3 is not included in the calculation of total 25OHD in serum. The aim of this study was to quantify 3-epi-25OHD3 concentrations in maternal-cord dyads around the time of delivery. A total of 82 cord blood samples were collected and within a week of delivery, matched maternal samples were drawn. Serum 25OHD2, 25OHD3, and 3-epi-25OHD3 were extracted, separated and quantified using an LC-MS/MS method, which is traceable to the US National Institute for Standards and Technology (NIST) higher order reference measurement procedure( Reference Tai, Bedner and Phinney 3 ).

Mean (sd) of maternal and cord serum 25OHD3 concentrations were 38.2 (21) and 25.4 (15) nmol/L, respectively (P<0.001). 3-epi-25OHD3 was detected in all maternal and cord samples and while there was no significant difference between them (P=0.056), cord 3-epi-25OHD3 concentrations were 118% of maternal levels on average. The relative percentage of 3-epi-25OHD3 over 25OHD3 was significantly higher in cord samples (P<0.001), see table.

Levels of 3-epi-25OHD3 in mothers and cords tracked the seasonal variation in 25OHD3, see Figure. There were strong associations between maternal and cord concentrations of 25OHD3 (r=0.868) and the 3-epi-25OHD3 (r=0.672), (both P<0.001). In mothers, the association between serum 25OHD3 and the 3-epi-25OHD3 was r=0.902 and in cord serum was r=0.782 (both P<0.001).

The ubiquitous presence of 3-epi-25OHD3 in human serum, the strong correlation with 25OHD3, and the relatively large proportion of the epimer in cord blood are of interest. Although the concentrations of 3-epi-25OHD3 are not currently included in the estimate of total 25OHD, separate quantification of the epimer might be especially important for infants to provide a more complete estimate of total serum 25OHD concentrations, should the epimer have biological function and clinical significance.

Supported by the Higher Education Authority Program for Research in Third Level Institutions (PRTLI Cycle 4)

References

1. Strathmann, FG, Sadilkova, K, Laha, TJ et al. (2012) Clin Chim Acta 413, 203–206.Google Scholar
2. Stepman, HC, Vanderroost, A, Stöckl, D, Thienpont, LM (2012) Clin Chem Lab Med 49, 253–6.Google Scholar
3. Tai, SSC, Bedner, M, Phinney, KW (2010) Ana Chem 82, 1942–1948.Google Scholar